Special Issue

Topic: Surgical Resection for HCC: Insights into the Indications and the Prognosis

A Special Issue of Hepatoma Research

ISSN 2454-2520 (Online) 2394-5079 (Print)

Submission deadline: 30 May 2023

Guest Editor(s)

Allan Tsung, MD
Director of Department of Surgical Oncology, the Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Special Issue Introduction



Special Issue webinar: Surgical Resection for HCC: Insights into the Indications and the Prognosis

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and as the risk factors associated with HCC continue to the rise, so will the incidence of HCC. Treatment algorithms for patients with HCC are complex taking into account not only the extent of tumor burden but also the patient's underlying liver dysfunction. Surgical resection remains a cornerstone of treatment for patients with HCC offering a potential chance for cure. Surgical resection is guided by both tumor burden and liver physiology where the surgeon must balance a complete tumor extirpation with leaving an adequate future liver remnant. Despite this, many patients are not surgical candidates for reasons including both patient and tumor factors. In addition, recurrence rates after resection remain high where up to seventy percent of patients experience disease recurrence in the liver at five years. In this edition of Hepatoma Research, we discuss the role of surgical resection as well as combination strategies for the treatment of patients with HCC.

The following topics are what we want to discuss in this Special Issue:
1. Criteria for Resection Beyond Barcelona Staging: Resecting the Aggressive Tumor
2. Resection of the Diseased Liver and the Patient's Physiologic Reserve
3. Management of the Future Liver Remnant: Strategies to Promote Hepatic Hypertrophy
4. Strategies of Tumor Downstaging for Resection
5. Resection versus Liver Transplant in the Well Compensated Liver
6. The Role of Minimally Invasive Surgery in the Treatment of HCC
7. Non-Resection Options for the Potentially Resectable HCC
8. Resection Strategy: Anatomic versus Non-Anatomic Resection
9. Surgical Treatment of Intra-Hepatic Recurrence
10. Adjuvant Treatment of HCC after Resection

Submission Deadline

30 May 2023

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/hr/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=hr&SpecialIssueId=521
Submission Deadline: 30 May 2023
Contacts: Victoria Lee, Assistant Editor, editor_Victoria@hrjournal.net

Published Articles

The role of minimally invasive surgery in the treatment of HCC

Open Access Review DOI: 10.20517/2394-5079.2022.14 15 May 2022
Views: Downloads:
Download PDF

Adjuvant treatment of hepatocellular carcinoma after resection

Open Access Review DOI: 10.20517/2394-5079.2021.85 14 Oct 2021
Views: Downloads:
Download PDF

Anatomic vs. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises?

Open Access Review DOI: 10.20517/2394-5079.2021.66 14 Oct 2021
Views: Downloads:
Download PDF

Management of future liver remnant: strategies to promote hepatic hypertrophy

Open Access Review DOI: 10.20517/2394-5079.2021.49 2 Sep 2021
Views: Downloads:
Download PDF

Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor

Open Access Review DOI: 10.20517/2394-5079.2021.51 1 Sep 2021
Views: Downloads:
Download PDF
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/